A Stem Cell Canard Returns!

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.

In the National Review Kathryn Jean Lopez is touting, once again, adult-stem-cell research as the wave of the future, arguing that “embryonic-stem-cell is not the only hope for mankind,” and hence, there’s no need to pursue it. After all, adult stem cells are already being used for a variety of cures, whereas no one has ever been healed by embryonic stem cells. Well, okay, but nothing here logically rules out the future utility or even necessity of embryonic cells. Obviously the best thing to do from a scientific standpoint would be to pursue both—which, as it happens, is exactly what the International Society for Stem Cell Research has recommended.

Lopez then cites the pro-adult-stem-cell work of Michael Fumento, whose work on stem cell research was reviewed in Nature Biotech thusly:

The imprint of Fumento’s worldview is also evident in his chapter on stem cell research. It is clear that he finds embryonic stem cell research morally problematic. Yet, according to Fumento, the ethical dilemma over funding for embryo research could be rendered obsolete if focus were placed instead on adult stem cell research. Starting with the answer that adult stem cell research is good and embryonic stem cell research is bad, Fumento devotes his chapter on the topic to arguing that only adult stem cell research offers the potential for treatments and cures within the next few years, whereas much doubt clouds the possibility for success with embryonic research.

He also attempts to debunk the claim that adult stem cells are more limited in their plasticity than their embryonic counterparts, and argues that adult stem cells “may be superior in all ways.” Fumento insists that the embryonic stem cell research movement has been spearheaded by scientists with strong economic ties to the research, and that both journalists and politicians have been hoodwinked by the appeals of these scientists and their “disinformation” campaign.

Okay, so Fumento seems less a dispassionate scientist and more of an ideologue, but that doesn’t mean he’s wrong about everything. But it’s also a bit silly to ignore the strong scientific case for embryonic stem cell research: namely, that they are far more plastic than adult stem cells, can be used to generate any tissue in the body, and hence may one day be far more useful for curing degenerative diseases. Adult stem cells are almost certainly not “superior in all ways,” although a slew of right-wing researchers keep trumpeting shoddy results to try to prove otherwise. At any rate, the point here is that Lopez morally disapproves of embryonic-stem-cell research. Well, fine, but that’s no excuse for pretending to have scientific “evidence” to back up those vague moral feelings.


Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend